Cargando…

Does KRAS Testing in Metastatic Colorectal Cancer Impact Overall Survival? A Comparative Effectiveness Study in a Population-Based Sample

PURPOSE: Epidermal growth factor receptor (EGFR) inhibitors are approved for treating metastatic colorectal cancer (CRC); KRAS mutation testing is recommended prior to treatment. We conducted a non-inferiority analysis to examine whether KRAS testing has impacted survival in CRC patients. PATIENTS A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feigelson, Heather Spencer, Zeng, Chan, Pawloski, Pamala A., Onitilo, Adedayo A., Richards, C. Sue, Johnson, Monique A., Kauffman, Tia L., Webster, Jennifer, Nyirenda, Carsie, Alexander, Gwen L., Hwang, Clara, Cross, Deanna, McCarty, Catherine A., Davis, Robert L., Schwarzkopf, Denise, Williams, Andrew E., Honda, Stacey, Daida, Yihe, Kushi, Lawrence H., Delate, Thomas, Goddard, Katrina A. B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006772/ https://www.ncbi.nlm.nih.gov/pubmed/24788807 http://dx.doi.org/10.1371/journal.pone.0094977

Ejemplares similares

Oncologists' attitudes toward KRAS testing: a multisite study
por: Harris, Julie N, et al.
Publicado: (2013)

Reliability of KRAS mutation testing in metastatic colorectal cancer patients across five laboratories
por: Feigelson, Heather Spencer, et al.
Publicado: (2012)

Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
por: Bowles, Erin J. Aiello, et al.
Publicado: (2012)

New Genetic Variants Improve Personalized Breast Cancer Diagnosis
por: Liu, Jie, et al.
Publicado: (2014)

Leveraging Interaction between Genetic Variants and Mammographic Findings for Personalized Breast Cancer Diagnosis
por: Liu, Jie, et al.
Publicado: (2015)

A population-based survey to assess the association between cannabis and quality of life among colorectal cancer survivors
por: Calcaterra, Susan L., et al.
Publicado: (2020)

Population based allele frequencies of disease associated polymorphisms in the Personalized Medicine Research Project
por: Cross, Deanna S, et al.
Publicado: (2010)

Development of a fingerprinting panel using medically relevant polymorphisms
por: Cross, Deanna S, et al.
Publicado: (2009)

Systematic review of the predictive effect of MSI status in colorectal cancer patients undergoing 5FU-based chemotherapy
por: Webber, Elizabeth M, et al.
Publicado: (2015)

Is oestrogen receptor-negative/progesterone receptor-positive (ER−/PR+) a real pathological entity?
por: Onitilo, Adedayo A, et al.
Publicado: (2021)

Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system
por: Muessig, Kristin R., et al.
Publicado: (2022)

Development of an evidence-based model for predicting patient, provider, and appointment factors that influence no-shows in a rural healthcare system
por: Shour, Abdul R., et al.
Publicado: (2023)

Evaluating the adoption of voice recognition technology for real-time dictation in a rural healthcare system: A retrospective analysis of dragon medical one
por: Onitilo, Adedayo A., et al.
Publicado: (2023)

Utilization of Neoadjuvant Chemotherapy Varies in the Treatment of Women with Invasive Breast Cancer
por: Onitilo, Adedayo A., et al.
Publicado: (2013)

Evaluation of Diagnostic Workup and Etiology of Hypercalcemia of Malignancy in a Cohort of 167 551 Patients Over 20 Years
por: Sheehan, Michael T, et al.
Publicado: (2021)

Frequency of Parathyroid Hormone Assessment in the Evaluation of Hypercalcemia. A Comparison Between Patients With and Without a History of Malignancy in a 20-year Dataset of 20,954 Patients
por: Sheehan, Michael T, et al.
Publicado: (2021)

Dietary intake in the Personalized Medicine Research Project: a resource for studies of gene-diet interaction
por: Strobush, Lacie, et al.
Publicado: (2011)

Development and Validation of the Minnesota Assessment of Pharmacogenomic Literacy (MAPL)
por: Allen, Josiah D., et al.
Publicado: (2022)

Evaluating cancer genetic services in a safety net system: overcoming barriers for a lasting impact beyond the CHARM research project
por: Okuyama, Sonia, et al.
Publicado: (2023)

Unique Case Report of a Meningeal Sarcoma Arising during Ongoing Treatment for Progressing Intraparenchymal Glioma
por: Peterson, Richard A., et al.
Publicado: (2019)

A novel method for studying the temporal relationship between type 2 diabetes mellitus and cancer using the electronic medical record
por: Onitilo, Adedayo A, et al.
Publicado: (2014)

Your neighborhood matters: an ecological social determinant study of the relationship between residential racial segregation and the risk of firearm fatalities
por: Shour, Abdul R., et al.
Publicado: (2023)

Patient Characteristics and Utilization Patterns of Short-Acting Recombinant Granulocyte Colony-Stimulating Factor (G-CSF) Biosimilars Compared to Their Reference Product
por: Mendelsohn, Aaron B., et al.
Publicado: (2021)

Characteristics of State Legislation Addressing Prescription Drug Price Increases in the United States, 2020
por: Shahriar, Arman A., et al.
Publicado: (2021)

Increased Risk of Colon Cancer in Men in the Pre-Diabetes Phase
por: Onitilo, Adedayo A., et al.
Publicado: (2013)

Cinacalcet for the Treatment of Humoral Hypercalcemia of Malignancy: An Introductory Case Report with a Pathophysiologic and Therapeutic Review
por: Sheehan, Michael, et al.
Publicado: (2020)

Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system
por: Crain, Philip R., et al.
Publicado: (2022)

Improving quality of breast cancer surgery through development of a national breast cancer surgical outcomes (BRCASO) research database
por: Aiello Bowles, Erin J, et al.
Publicado: (2012)

La enseñanza : su orientación, sus funciones, sus motivaciones
por: Hammonds, Carsie, 1894-
Publicado: (1972)

El proceso enseñanza aprendizaje
por: Hammonds, Carsie, 1894-
Publicado: (1979)

Public Attitudes toward Pharmacogenomic Testing and Establishing a Statewide Pharmacogenomics Database in the State of Minnesota
por: Zhang, Lusi, et al.
Publicado: (2022)

“Is It Worth Knowing?” Focus Group Participants’ Perceived Utility of Genomic Preconception Carrier Screening
por: Schneider, Jennifer L., et al.
Publicado: (2015)

A review of breast cancer pathology reports in Nigeria
por: Joseph, Adedayo O, et al.
Publicado: (2021)

Protocol for the “Implementation, adoption, and utility of family history in diverse care settings” study
por: Wu, R. Ryanne, et al.
Publicado: (2015)

The NextGen Study: patient motivation for participation in genome sequencing for carrier status
por: Kauffman, Tia L., et al.
Publicado: (2017)

Assessment of willingness to pay for expanded carrier screening among women and couples undergoing preconception carrier screening
por: Clarke, Elizabeth V., et al.
Publicado: (2018)

Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study
por: Guo, Boya, et al.
Publicado: (2023)

Indoloquinoline-Mediated Targeted Downregulation of KRAS through Selective Stabilization of the Mid-Promoter G-Quadruplex Structure
por: Psaras, Alexandra Maria, et al.
Publicado: (2022)

Design of a randomized controlled trial for genomic carrier screening in healthy patients seeking preconception genetic testing
por: Kauffman, Tia L., et al.
Publicado: (2016)

Assessment of Oral Chemotherapy Nonadherence in Chronic Myeloid Leukemia Patients Using Brief Measures in Community Cancer Clinics: A Pilot Study
por: Davis, Terry C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rq0mut9m6rog0vo22n7f99vvvi